Skip to main content
SpringerLink
Log in

Interférences avec l’hémostase

  • Chapter
Book cover Sepsis sévère et choc septique

Part of the book series: Le point sur⋯ ((POINT))

  • 340 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Corrigan JJ, Ray WL, May N (1968) Changes in the blood coagulation system associated septicemia. N Engl J Med 279: 851–6

    PubMed  Google Scholar 

  2. Esmon CT (1998) Inflammation and thrombosis: mutual regulation by protein C. Immunologist 6: 84–9

    CAS  Google Scholar 

  3. Vallet B, Wiel E (2001) Endothelial cell dysfunction and coagulation. Crit Care Med 29: S36–41

    CAS  PubMed  Google Scholar 

  4. Levi M, ten Cate H (1999) Disseminated intravascular coagulation. N Engl J Med 341: 586–92

    Article  CAS  PubMed  Google Scholar 

  5. Marshall JC (2001) Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 29: S99–106

    CAS  PubMed  Google Scholar 

  6. Ruggeri ZM (1994) New insights into the mechanisms of platelet adhesion and aggregation. Semin Hematol 31: 229–39

    CAS  PubMed  Google Scholar 

  7. Cines DB, Pollak ES, Buck CA et al. (1998) Endothelial cells in physiology and pathophysiology of vascular disorders. Blood 91: 3527–61

    CAS  PubMed  Google Scholar 

  8. Rao LVM, Rapaport SI (1987) Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation. Blood 69: 645–51

    CAS  PubMed  Google Scholar 

  9. Esmon CT (1989) The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 264: 4743–6

    CAS  PubMed  Google Scholar 

  10. Stearns-Kurosawa DJ, Kurosawa S, Mollica JS et al. (1996) The endothelial cell protein C receptor augments protein C activation by thrombin-antithrombomodulin complex. Proc Natl Acad Sci USA 93: 10212–6

    Article  CAS  PubMed  Google Scholar 

  11. Walker FJ (1981) Regulation of activated protein C by protein S: the role of phospholipid in factor Va inactivation. J Biol Chem 256: 11128–31

    CAS  PubMed  Google Scholar 

  12. Astrup T (1991) Fibrinolysis: past and present. A reflection of fifty years. Sem Thromb Hemost 17: 161–74

    CAS  Google Scholar 

  13. Esmon CT (1999) New potential therapeutic modalities: aPC. Sepsis 3: 161–71

    Article  Google Scholar 

  14. Nawroth PP, Handley DM (1986) Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 163: 740–5

    CAS  PubMed  Google Scholar 

  15. Faust SN, Levin M, Harrison OB et al. (2001) Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 345: 408–16

    Article  CAS  PubMed  Google Scholar 

  16. Coughlin SR (1994) Thrombin receptor function and cardiovascular disease. Trends Cardiovasc Med 4: 77–83

    Article  CAS  Google Scholar 

  17. Voss R, Matthias FR, Borkowski G, Reitz D (1990) Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit. Br J Haematol 75: 99–105

    CAS  PubMed  Google Scholar 

  18. Eisele B, Lamy M, Thijs LG et al. (1998) Antithrombin III in severe sepsis. A randomized, placebo-controlled, double blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled double blind trials with antithrombin III in severe sepsis. Intensive Care Med 24: 663–72

    Article  CAS  PubMed  Google Scholar 

  19. Warren BL, Eid A, Singer P et al. (2001) Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 286: 1869–78

    CAS  PubMed  Google Scholar 

  20. Abraham E, Reinhart K, Opal S (2003) Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 290: 238–47

    Article  CAS  PubMed  Google Scholar 

  21. Bernard GR, Vincent JL, Laterre PF et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699–709

    Article  CAS  PubMed  Google Scholar 

  22. Warren HS, Suffredini AF, Eichacker PQ, Munford RS (2002) Risks and benefits of activated protein C treatment for severe sepsis. N Engl J Med 347: 1027–30

    Article  PubMed  Google Scholar 

  23. Siegel JP (2002) Assessing the use of activated protein C in the treatment of severe sepsis. N. Engl. J. Med 347: 1030–4

    Article  PubMed  Google Scholar 

  24. Angus DC, Linde-Zwirble WT, Clermont G (2003) Cost-effectiveness of dotrecogin alfa (activated) in the treatment of severe sepsis. Crit Care Med 31: 1–11

    PubMed  Google Scholar 

  25. Davidson BL, Geerts WH, Lensing AWA (2002) Low-dose heparin for severe sepsis. N Engl J Med 347: 1036–7

    Article  PubMed  Google Scholar 

  26. Kerlin BA, Yan SB, Isermann BH (2003) Survival advantage associated with heterozygocis factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia. Blood 102: 3085–92

    Article  CAS  PubMed  Google Scholar 

  27. Dhainaut JF (2000) Sepsis et hémostase: nouvelles perspectives thérapeutiques. Reanim Urg 9(suppl 2): 51–63

    Google Scholar 

Download references

Authors
  1. C. Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Vallet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Wiel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag France

About this chapter

Cite this chapter

Martin, C., Vallet, B., Wiel, E. (2005). Interférences avec l’hémostase. In: Sepsis sévère et choc septique. Le point sur⋯. Springer, Paris. https://doi.org/10.1007/2-287-27496-0_17

Download citation

  • DOI: https://doi.org/10.1007/2-287-27496-0_17

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-22072-2

  • Online ISBN: 978-2-287-27496-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation